We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Home
Services
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
1 February 2023
VISCHER advised Oberland Capital Management LLC on its financing agreement with the Helsinn Group. Oberland Capital is a private investment firm with assets under management in excess of USD 3 bn, focused exclusively on investing in the global healthcare industry and specializing in flexible investment structures customized to meet the specific needs of its transaction partners. The Helsinn Group is a fully integrated, global biopharma group with a track record of over 40 years of commercial execution and a strong focus in oncology and rare diseases. VISCHER acted as Swiss legal advisor to Oberland Capital in this transaction. The team was led by Adrian Dörig (Partner, Banking & Finance) and included Christoph Niederer (Partner, Tax), Jana Essebier (Partner, Banking & Finance), Jonas Gassmann (Counsel, IP), Seraina Jenny-Tsering (Managing Associate, Banking & Finance), Christian Schneiter (Senior Associate, Banking & Finance), Patrik Fisch (Senior Associate, Tax), Livia Camenisch (Associate, IP) and Dorothea Wirth (Junior Associate, Banking & Finance).
Category: Banking & Finance
Attorney at Law
Attorney at Law, Swiss Certified Tax Expert
M.A. HSG in Law et M.A. HSG in Accounting and Finance
Junior Associate
Fangda Carbon New Material Co., Ltd., an integrated carbon materials producer in in the People's...
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.
On 28 July 2022, Ningbo Shanshan Co. raised USD 310.5m through GDRs issuance and listing on the SIX...